Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Regulatory Post-Marketing Surveillance (rPMS) Study for Leqvio® Pre-filled Syringe(Inclisiran Sodium)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06770543
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:46.450124+00:00
Published At
2025-12-22T00:00:00+00:00
Record Updated At
2025-12-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Primary Hypercholesterolemia or Mixed Dyslipidemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-22"
protocolSection.identificationModule.nctId
"NCT06770543"
protocolSection.identificationModule.officialTitle
"Regulatory Post-Marketing Surveillance (rPMS) Study for Leqvio\u00ae Pre-filled Syringe(Inclisiran Sodium)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Primary Hypercholesterolemia or Mixed Dyslipidemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.